Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment
European Journal of Cancer2017Vol. 77, pp. 117–126
Citations Over TimeTop 10% of 2017 papers
Xiong Zou, Rui You, Huai Liu, Yu-Xiang He, Guo-Feng Xie, Zhihai Xie, Jibin Li, Rou Jiang, Li-Zhi Liu, Li Li, Meng-Xia Zhang, You-Ping Liu, Yi-Jun Hua, Ling Guo, Chao-Nan Qian, Hai-Qiang Mai, Dong-Ping Chen, Ying Luo, Liang-Fang Shen, Ming‐Huang Hong, Ming‐Yuan Chen
Related Papers
- Quantitative detection of epstein-Barr virus infectious status in nasopharyngeal carcinoma tissues(2010)
- Correlation between Epstern-Barr virus andangiogenesis of patients with nasopharyngeal carcinoma(2011)
- Value Analysis of Plasma Epstein-barr Virus DNA Concentration Detection in Screening and Clinical Staging Diagnosis of Nasopharyngeal Carcinoma(2020)
- → Data from Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China(2023)
- → Data from Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China(2023)